Enovis Corporation (ENOV) Stock Analysis
A live, multi-source view of Enovis Corporation (ENOV): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Enovis Corporation
Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions.
Sector: Healthcare · Industry: Medical Devices · United States · 7,802 employees · enovis.com
Key statistics · as of 2026-09-05
As of 2026-09-05, Enovis Corporation (ENOV) had a market capitalization of $1.07B (forward 5.0) and a beta of 1.43; the shares traded in a 52-week range of $18.52 – $34.28 (-38.2% over the year).
- Market cap
- $1.07B
- Enterprise value
- $2.48B
- Forward P/E
- 5.0
- PEG ratio
- 3.45
- Price / book
- 0.72
- EPS (trailing)
- $-19.27
- EPS (forward)
- $3.69
- Payout ratio
- 0.0%
- 52-week range
- $18.52 – $34.28
- 52-week change
- -38.2%
- Beta
- 1.43
- Average volume
- 1.2M
- Shares outstanding
- 57.7M
- Short % of float
- 18.01%
- Profit margin
- -48.0%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-11
In RapidTradeView’s 2026-09-11 scan of the US universe, Enovis Corporation (ENOV) last closed at $18.41 (the last completed close before that scan).
Technicals at the scan: RSI 30 (oversold territory), price -21.2% versus its 20-day average, 20-day versus 50-day average spread -7.7%, MACD histogram -0.63.
Sentiment inputs: StockTwits 100% bullish; analyst consensus score 77/100.
Next scheduled company event: in 54 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 0 buys and 0 sells of ENOV; corporate insiders filed 4 buys and 0 sells (2 distinct filers, latest disclosure 2026-09-08). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Oliver Engert (3B/0S), Damien Mcdonald (1B/0S). Who is trading what
RapidTradeView pick record
ENOV has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Enovis Corporation (ENOV) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell ENOV.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.